The in vitro diagnostics market continues to attract the interest of healthcare provider’s alike worldwide, since clinical testing is used for 70 percent of healthcare decisions and can help provide more targeted therapy at a lower cost. In the past few years clinical laboratory technology has changed dramatically with groundbreaking innovations in gene editing, next generation sequencing, microbiome research, and direct-to-consumer testing.
Nowadays IVDs are a critical factor in determining healthcare needs. Medical decisions are taken on basis of information provided by IVDs. They help guide clinical decisions on what treatment or intervention will be most appropriate, ranging from managing cholesterol levels to detecting genetic conditions. At an even earlier stage, IVDs can be used to detect conditions even before signs of illness, often saving a great deal of suffering and at times unnecessary treatment.
In many conditions, the early diagnosis provided by an IVD can provide better long term outcomes, by highlighting a need for treatment or lifestyle changes. In some cases, such as certain cancers, the information from an IVD test can help prevent premature death. Diagnostics also play an important role in public health programs, such as population screening for communicable diseases.